IDEX Finally Answers the Question It Has Been Dodging for Five Quarters

Orders near $1B and a raised outlook are the headline; the real news is a short-cycle industrial floor that stopped sagging — and a new word, 'tunability,' for how IDEX redeploys component tech into hotter markets

IEX · Earnings Call · 2026-10-28

The question that finally got a different answer

For five straight calls, analysts asked some version of the same thing: are your bellwether, rapid-replenishment businesses inflecting? In April the answer was a month-by-month shrug — “weak in January, a little better in February, pretty strong March, and then it sort of held at that level in April” — Eric Ashleman, Chief Executive Officer · 2026-04-29. In July it was still frozen decision-making that only thawed in the final weeks of the quarter. On Wednesday, Eric Ashleman finally gave a different answer: “nice little step ups in the ... broader kind of small volume order rates” — Eric D. Ashleman, Chief Executive Officer · 2026-10-28, with September's pattern carrying into October, and two of the three "fatigued" verticals — ag and energy — staging orders ahead of next year's planning season. That is small in dollars and management refused to oversell it. But it changes the character of the beat. Q3 organic sales grew 8% against a 5–7% guide, adjusted EPS of $2.33 cleared a $2.20–$2.25 range, and orders reached nearly $1 billion, up 13% organically. The full-year outlook moved to 6.5–6.8% organic from 5–6%, and EPS to $8.91–$8.96 from $8.70–$8.85. Crucially, the industrial side of the house showed up rather than being carried by the secular story.

"Tunability": a new word for a real mechanism

The fresh vocabulary of this call was tunability — the idea that IDEX's component-level position lets it swing the same technical capability laterally into faster-growing verticals at low cost to the customer. Porous-metal filtration for legacy energy became atomic-level purity for semiconductors at Mott; electroforming for respiratory care became fiber alignment for optical circuit switching at Muon. Ashleman was explicit that this is not a TAM story he has told before: “it does absolutely elevate the potential TAM of things to do there” — Eric D. Ashleman, Chief Executive Officer · 2026-10-28. That framing matters because it is the first coherent answer to the bear case that has dogged this stock since the acquisition spree — that IDEX overpaid for businesses outside its lane. The answer is arithmetic. The three advantage markets of data center, semiconductor, and space/defense now sit above a third of HST, and as Sean Gillen put it, “in aggregate, they are now over a third of the portfolio” — Sean Gillen, Chief Financial Officer · 2026-10-28, running roughly 50% year-over-year growth in aggregate. A quarter that once looked like a narrow slice is now the plurality of the segment. Seven quarters ago the same management team was describing this as a story "building over the last 1.5 years"; the difference today is that HST orders of $468 million, up 21%, are a third-quarter record rather than a promise.

2026, I think, has really been a validation of our strategic thesis. That drove the acquisition strategy over the last 5 years.
Eric D. Ashleman, Chief Executive Officer · 2026-10-28

FMT stops being the punchline

The quieter but more consequential shift is in FMT, the segment management planned flat for the year. In April the CFO was still telling investors to expect “a growth outlook that's a bit flat” — Sean Gillen, Chief Financial Officer · 2026-04-29. It printed 4% organic in Q3 with orders up 11% to a record $349 million, led by semiconductor and municipal water, with sequential improvement in chemical valves and agriculture even as both remain down year over year. Ashleman was blunt that chemicals is the one area still genuinely sick, pinned to elevated input pricing. That is the broadening that has been missing. The company's own bellwether thesis — that when five or six rapid-fulfillment businesses move together, something real is happening — has been invoked on every call since 2025 without ever being triggered. It is now being invoked with evidence.

What the tape is saying that the call isn't

Here is the contrast worth holding onto. Globally, AI data center exposure is a 90-day decliner — the market's AI-datacenter basket is down about 5% on average with six advancers against fifty decliners. IDEX is up 7.9% over the same window. So the stock has been paid for the theme while the theme's own tape has been fading, which is either relative strength or a lag waiting to be marked down. Management gave the bears an opening on this. Asked about HST's visibility, Ashleman conceded “the data center piece in particular is gonna be a little lumpy, a little unpredictable” — Eric D. Ashleman, Chief Executive Officer · 2026-10-28 — order streams arrive in tranches calibrated by customers' own supply chains, not IDEX's. A quarter earlier he had called the same visibility “a relatively narrow corridor that we're describing here” — Eric Ashleman, CEO · 2026-07-29. Nothing in that has changed; only the surrounding growth has. And it is a shared theme, not a proprietary one. Other reporters this week — KLA on sustained AI data center investment, Johnson Controls on cold plates for data centers, Celestica on integrated optics — are all selling the same adjacent plumbing. IDEX's claim is narrower and defensible: mission-critical components at a small share of total system cost, which is why it can still price in excess of cost to the tune of roughly 2% of the top line in 2026.

The numbers behind the narrative

The P&L supports the story without fully confirming it. Revenue of $921 million was up 6% year over year on a reported basis with gross margin at 46.4%, up a full point. But operating margin of 21.7% remains four points below its 2023 peak of 25.0% — much of that gap is purchase-accounting amortization from the very acquisitions now driving growth, but it means the "high 30s to 40%" incremental margin framework is still a promise rather than a print. Cash is where the model earns its keep: free cash flow margin of 18.6%, with $214 million of Q3 free cash flow at 124% conversion. That funded $77 million of repurchases, with management guiding to roughly $75 million per quarter through year-end, and gross leverage down to 1.8x from 2.1x. With net debt of about $1.2 billion and an active bolt-on pipeline — "activity level really, really high," per Ashleman, though private-market valuations remain stubborn — the capital allocation flywheel has room. At 32x trailing earnings the stock is not cheap for an 8% organic grower. The question the next two quarters must answer is whether the broadening in FMT and the short-cycle day rates is a durable turn or a single good print, and whether the data-center tranches keep arriving on schedule. For the first time in five quarters, the burden of proof has shifted from management to the doubters.